Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Targeting microglial P2Y12-receptor signalling attenuates neurodegeneration in experimental Parkinson’s disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Update: Descriptive epidemiology of Parkinson disease
10.1016/j.parkreldis.2024.106000 · 2024 · External reference
10.1038/nrn983
10.1038/nrn983 · External reference
10.1016/j.neubiorev.2016.07.010
10.1016/j.neubiorev.2016.07.010 · External reference
10.1016/s0140-6736(21)00218-x
10.1016/s0140-6736(21)00218-x · External reference
10.1016/j.cger.2019.08.002
10.1016/j.cger.2019.08.002 · External reference
10.1038/ng.487
10.1038/ng.487 · External reference
10.1038/s41577-022-00684-6
10.1038/s41577-022-00684-6 · External reference
10.1002/ana.26032
10.1002/ana.26032 · External reference
10.1111/bph.15005
10.1111/bph.15005 · External reference
Strategies for targeting the P2Y(12) receptor in the central nervous system
10.1016/j.bmcl.2022.128837 · 2022 · External reference
Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the Brain
10.1021/acs.jmedchem.5c00457 · 2025 · External reference
10.1212/nxi.0000000000000080
10.1212/nxi.0000000000000080 · External reference
10.1038/nn1805
10.1038/nn1805 · External reference
10.1126/science.aax6752
10.1126/science.aax6752 · External reference
10.1016/j.bbi.2010.02.010
10.1016/j.bbi.2010.02.010 · External reference
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes
10.1097/00005072-199209000-00009 · 1992 · External reference
10.1155/2018/4784268
10.1155/2018/4784268 · External reference
10.1016/j.phrs.2021.106045
10.1016/j.phrs.2021.106045 · External reference
10.1038/nature21029
10.1038/nature21029 · External reference
10.1001/jama.2019.22360
10.1001/jama.2019.22360 · External reference
10.1056/nejmct0800326
10.1056/nejmct0800326 · External reference
10.1186/s13041-019-0492-x
10.1186/s13041-019-0492-x · External reference
10.1371/journal.pbio.3000411
10.1371/journal.pbio.3000411 · External reference
10.1111/bph.15178
10.1111/bph.15178 · External reference
Unresolved reference
2025 · External reference
10.1038/nn.2467
10.1038/nn.2467 · External reference
10.1016/j.celrep.2023.113031
10.1016/j.celrep.2023.113031 · External reference
10.1084/jem.20211071
10.1084/jem.20211071 · External reference
10.1073/pnas.0813361106
10.1073/pnas.0813361106 · External reference
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease
2016 · External reference
Stereological Estimation of Dopaminergic Neuron Number in the Mouse Substantia Nigra Using the Optical Fractionator and Standard Microscopy Equipment
2017 · External reference
10.1002/ar.1092310411
10.1002/ar.1092310411 · External reference
10.1016/s1385-299x(01)00064-2
10.1016/s1385-299x(01)00064-2 · External reference
10.1016/j.bbrep.2021.100916
10.1016/j.bbrep.2021.100916 · External reference
10.1016/0304-3894(92)87011-4
10.1016/0304-3894(92)87011-4 · External reference
10.1038/jcbfm.2009.113
10.1038/jcbfm.2009.113 · External reference
10.1523/jneurosci.1227-10.2010
10.1523/jneurosci.1227-10.2010 · External reference
10.1038/nature13083
10.1038/nature13083 · External reference
10.1093/nar/gkac1013
10.1093/nar/gkac1013 · External reference
Unresolved reference
External reference
10.1021/acs.jctc.1c00302
10.1021/acs.jctc.1c00302 · External reference
10.1007/s10822-015-9858-z
10.1007/s10822-015-9858-z · External reference
Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
10.1021/acschemneuro.6b00029 · 2016 · External reference
10.1021/acs.jmedchem.9b01220
10.1021/acs.jmedchem.9b01220 · External reference
10.1093/bioinformatics/btaa918
10.1093/bioinformatics/btaa918 · External reference
10.3389/fnins.2022.858126
10.3389/fnins.2022.858126 · External reference
10.1111/jth.12719
10.1111/jth.12719 · External reference
10.1111/j.1476-5381.1959.tb00928.x
10.1111/j.1476-5381.1959.tb00928.x · External reference
10.1046/j.1365-2125.2003.01880.x
10.1046/j.1365-2125.2003.01880.x · External reference
10.4103/0253-7176.116232
10.4103/0253-7176.116232 · External reference
10.3758/brm.41.4.1149
10.3758/brm.41.4.1149 · External reference
10.1111/jth.13684
10.1111/jth.13684 · External reference
10.1186/s13195-015-0139-9
10.1186/s13195-015-0139-9 · External reference
10.3390/ijms21020678
10.3390/ijms21020678 · External reference
10.1021/jm9003297
10.1021/jm9003297 · External reference
Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
2010 · External reference
10.1016/j.nbd.2014.06.011
10.1016/j.nbd.2014.06.011 · External reference
10.1016/s0223-5234(03)00012-6
10.1016/s0223-5234(03)00012-6 · External reference
Perivascular macrophages in the central nervous system: insights into their roles in health and disease
10.1038/s41419-025-07592-2 · 2025 · External reference
10.7554/elife.54590
10.7554/elife.54590 · External reference
10.1016/j.immuni.2012.12.001
10.1016/j.immuni.2012.12.001 · External reference
10.1038/nn.3531
10.1038/nn.3531 · External reference
Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina
10.1038/srep20636 · 2016 · External reference
10.1038/s41467-023-42096-7
10.1038/s41467-023-42096-7 · External reference
10.1002/glia.23097
10.1002/glia.23097 · External reference
Unresolved reference
2026 · External reference
10.3390/ijms22041636
10.3390/ijms22041636 · External reference
10.3892/mmr.2022.12607
10.3892/mmr.2022.12607 · External reference
10.3389/fnins.2015.00503
10.3389/fnins.2015.00503 · External reference
10.1007/s11910-008-0045-7
10.1007/s11910-008-0045-7 · External reference
10.4061/2011/658083
10.4061/2011/658083 · External reference
10.1016/j.neuron.2024.03.017
10.1016/j.neuron.2024.03.017 · External reference
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
10.1038/s41392-023-01588-0 · 2023 · External reference
10.1002/mds.10710
10.1002/mds.10710 · External reference
Hand muscle strength in Parkinson’s disease: A Sarcopenic epiphenomenon or a meaningful biomarker?
10.1016/j.parkreldis.2025.108021 · 2025 · External reference
Objective monitoring of motor symptom severity and their progression in Parkinson’s disease using a digital gait device
10.1038/s41598-025-09088-7 · 2025 · External reference
Cytokine activity in Parkinson’s disease
10.1042/ns20220063 · 2023 · External reference
Selective hydroboration of dieneamines. Formation of hydroxyalkylphenothiazines as MDR modulators
10.1016/j.bmc.2012.05.065 · 2012 · External reference
Synthesis and pharmacological investigation of new N-hydroxyalkyl- 2-aminophenothiazines exhibiting marked MDR inhibitory effect
10.1016/j.bmc.2013.04.034 · 2013 · External reference
10.1016/j.jacc.2010.11.024
10.1016/j.jacc.2010.11.024 · External reference
Exploring the therapeutic potential of phenothiazine derivatives in medicinal chemistry
10.1016/j.rechem.2024.101565 · 2024 · External reference
